341 related articles for article (PubMed ID: 24062406)
1. Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review.
Péron J; Maillet D; Gan HK; Chen EX; You B
J Clin Oncol; 2013 Nov; 31(31):3957-63. PubMed ID: 24062406
[TBL] [Abstract][Full Text] [Related]
2. Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review.
Péron J; Pond GR; Gan HK; Chen EX; Almufti R; Maillet D; You B
J Natl Cancer Inst; 2012 Jul; 104(13):982-9. PubMed ID: 22761273
[TBL] [Abstract][Full Text] [Related]
3. Endorsement for improving the quality of reports on randomized controlled trials of traditional medicine journals in Korea: a systematic review.
Choi J; Jun JH; Kang BK; Kim KH; Lee MS
Trials; 2014 Nov; 15():429. PubMed ID: 25373427
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of adverse event reporting in companion animal clinical trials evaluating cancer treatment.
Giuffrida MA
J Am Vet Med Assoc; 2016 Nov; 249(9):1079-1087. PubMed ID: 27767430
[TBL] [Abstract][Full Text] [Related]
5. Has the quality of abstracts for randomised controlled trials improved since the release of Consolidated Standards of Reporting Trial guideline for abstract reporting? A survey of four high-profile anaesthesia journals.
Can OS; Yilmaz AA; Hasdogan M; Alkaya F; Turhan SC; Can MF; Alanoglu Z
Eur J Anaesthesiol; 2011 Jul; 28(7):485-92. PubMed ID: 21037480
[TBL] [Abstract][Full Text] [Related]
6. Quality of reports on randomized controlled trials published in Iranian journals: application of the new version of consolidated standards of reporting trials (CONSORT).
Nojomi M; Ramezani M; Ghafari-Anvar A
Arch Iran Med; 2013 Jan; 16(1):20-2. PubMed ID: 23273230
[TBL] [Abstract][Full Text] [Related]
7. Identification, collection, and reporting of harms among non-industry-sponsored randomized clinical trials of pharmacologic interventions in the critically ill population: a systematic review.
Moskowitz A; Andersen LW; Holmberg MJ; Grossestreuer AV; Berg KM; Granfeldt A
Crit Care; 2020 Jul; 24(1):398. PubMed ID: 32641148
[TBL] [Abstract][Full Text] [Related]
8. Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations.
Smith SM; Wang AT; Katz NP; McDermott MP; Burke LB; Coplan P; Gilron I; Hertz SH; Lin AH; Rappaport BA; Rowbotham MC; Sampaio C; Sweeney M; Turk DC; Dworkin RH
Pain; 2013 Jul; 154(7):997-1008. PubMed ID: 23602344
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the quality of reporting of randomised controlled trials in otorhinolaryngologic literature - adherence to the CONSORT statement.
Peters JP; Hooft L; Grolman W; Stegeman I
PLoS One; 2015; 10(3):e0122328. PubMed ID: 25793517
[TBL] [Abstract][Full Text] [Related]
10. Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review.
Komorowski AS; MacKay HJ; Pezo RC
Cancer Med; 2020 Jul; 9(14):5035-5050. PubMed ID: 32452660
[TBL] [Abstract][Full Text] [Related]
11. Reporting quality of abstracts in phase III clinical trials of systemic therapy in metastatic solid malignancies.
Sivendran S; Newport K; Horst M; Albert A; Galsky MD
Trials; 2015 Aug; 16():341. PubMed ID: 26253548
[TBL] [Abstract][Full Text] [Related]
12. Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies.
Fung AE; Palanki R; Bakri SJ; Depperschmidt E; Gibson A
Ophthalmology; 2009 Feb; 116(2):286-96. PubMed ID: 19091408
[TBL] [Abstract][Full Text] [Related]
13. The use of and adherence to CTCAE v3.0 in cancer clinical trial publications.
Zhang S; Chen Q; Wang Q
Oncotarget; 2016 Oct; 7(40):65577-65588. PubMed ID: 27564109
[TBL] [Abstract][Full Text] [Related]
14. Adherence of randomized trials within children's surgical specialties published during 2000 to 2009 to standard reporting guidelines.
Blakely ML; Kao LS; Tsao K; Huang EY; Tsai A; Tanaka S; Younas S; Lu Z; Lally KP;
J Am Coll Surg; 2013 Sep; 217(3):394-399.e7. PubMed ID: 23969114
[TBL] [Abstract][Full Text] [Related]
15. Oncology trial abstracts showed suboptimal improvement in reporting: a comparative before-and-after evaluation using CONSORT for Abstract guidelines.
Ghimire S; Kyung E; Lee H; Kim E
J Clin Epidemiol; 2014 Jun; 67(6):658-66. PubMed ID: 24439069
[TBL] [Abstract][Full Text] [Related]
16. Reporting quality of randomized controlled trial abstracts published in leading laser medicine journals: an assessment using the CONSORT for abstracts guidelines.
Jin L; Hua F; Cao Q
Lasers Med Sci; 2016 Nov; 31(8):1583-1590. PubMed ID: 27365107
[TBL] [Abstract][Full Text] [Related]
17. Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review.
Williams MR; McKeown A; Pressman Z; Hunsinger M; Lee K; Coplan P; Gilron I; Katz NP; McDermott MP; Raja SN; Rappaport BA; Rowbotham MC; Turk DC; Dworkin RH; Smith SM
J Pain; 2016 Nov; 17(11):1137-1149. PubMed ID: 27522950
[TBL] [Abstract][Full Text] [Related]
18. Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy.
Bylicki O; Gan HK; Joly F; Maillet D; You B; Péron J
Ann Oncol; 2015 Jan; 26(1):231-237. PubMed ID: 25355720
[TBL] [Abstract][Full Text] [Related]
19. CONSORT compliance in surgical randomized trials: are we there yet? A systematic review.
Adie S; Harris IA; Naylor JM; Mittal R
Ann Surg; 2013 Dec; 258(6):872-8. PubMed ID: 23732263
[TBL] [Abstract][Full Text] [Related]
20. Information on adverse events in randomised clinical trials assessing drug interventions published in four medical journals with high impact factors.
Maggi CB; Griebeler IH; Dal Pizzol Tda S
Int J Risk Saf Med; 2014; 26(1):9-22. PubMed ID: 24796347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
